Detalhe da pesquisa
1.
Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer.
Breast Cancer Res Treat
; 184(1): 53-62, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32803633
2.
Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma.
EJHaem
; 3(2): 394-405, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846031
3.
Phase Ib study of combinations of avadomide (CC-122), CC-223, CC-292, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma.
EJHaem
; 3(1): 139-153, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846221
4.
Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer.
Clin Cancer Res
; 26(20): 5348-5357, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32694153
5.
Avadomide plus obinutuzumab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (CC-122-NHL-001): a multicentre, dose escalation and expansion phase 1 study.
Lancet Haematol
; 7(9): e649-e659, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32758434
6.
A First-in-Human Phase I Study of the Anticancer Stem Cell Agent Ipafricept (OMP-54F28), a Decoy Receptor for Wnt Ligands, in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 23(24): 7490-7497, 2017 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28954784
7.
Matrix-independent activation of phosphatidylinositol 3-kinase, Stat3, and cyclin A-associated Cdk2 Is essential for anchorage-independent growth of v-Ros-transformed chicken embryo fibroblasts.
J Biol Chem
; 278(21): 18798-810, 2003 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-12646574
8.
The role of phosphatidylinositol 3-kinase, rho family GTPases, and STAT3 in Ros-induced cell transformation.
J Biol Chem
; 277(13): 11107-15, 2002 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-11799110